865880-62-2

Basic information

• Product Name: C₇₉H₁₂₃NO₈
• Synonyms: C₇₉H₁₂₃NO₈
• CAS NO: 865880-62-2
• Molecular Weight: 1214.85
• Mol File: 865880-62-2.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: C₇₉H₁₂₃NO₈(CAS DataBase Reference)
• NIST Chemistry Reference: C₇₉H₁₂₃NO₈(865880-62-2)
• EPA Substance Registry System: C₇₉H₁₂₃NO₈(865880-62-2)

Safety Data

• Hazardous Substances Data: 865880-62-2(Hazardous Substances Data)

Upstream product

• 506-46-7 1-hexacosanoic acid 
• 799268-03-4 [(E)-(S)-1-((4S,5R)-2,2-Dimethyl-5-tetradecyl-[1,3]dioxolan-4-yl)-3-((2R,3S,4R,5S,6R)-3,4,5-tris-benzyloxy-6-benzyloxymethyl-tetrahydro-pyran-2-yl)-allyl]-carbamic acid tert-butyl ester 
• 205371-71-7 cerotic acid para-nitrophenyl ester 
• 60933-76-8 Acetic acid (2R,3S,4R,5S,6R)-3,5-diacetoxy-2-acetoxymethyl-6-vinyl-tetrahydro-pyran-4-yl ester 
• 856668-29-6 1,3,4,5-tetra-O-acetyl-2,6-anhydro-7,8,9-trideoxy-D-glycero-L-galacto-non-7-enitol 

Relevant articles and documents

Novel synthetic C-glycolipids, their synthesis and use to treat infections, cancer and autoimmune diseases

The invention is directed to novel compounds of formulae (I), (II) and (III): wherein X is O or NH; R3 is OH or a monosaccharide and R4 is hydrogen, or R3 is hydrogen and R4 is OH or a monosaccharide; R5 is hydrogen or a monosaccharide; and pharmaceutically acceptable salts or esters thereof. The invention is also directed to the use of the compounds both directly and as immune adjuvants for treating cancer, infectious diseases and autoimmune diseases. The invention is also directed to syntheses of the intermediates which can be used to make these novel compounds.